Prospect and progress of personalized peptide vaccinations for advanced cancers.
about
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.Further insight into AE37 peptide vaccination in prostate cancer.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.
P2860
Prospect and progress of personalized peptide vaccinations for advanced cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prospect and progress of personalized peptide vaccinations for advanced cancers.
@en
type
label
Prospect and progress of personalized peptide vaccinations for advanced cancers.
@en
prefLabel
Prospect and progress of personalized peptide vaccinations for advanced cancers.
@en
P2093
P2860
P1476
Prospect and progress of personalized peptide vaccinations for advanced cancers.
@en
P2093
Akira Yamada
Kyogo Itoh
Masanori Noguchi
Shinjiro Sakamoto
Tetsuro Sasada
P2860
P304
P356
10.1517/14712598.2016.1161752
P407
P577
2016-03-03T00:00:00Z